Doctors Unload on Kourtney Kardashian's 'Ozempic' Pills: Dangerous Fad or Cellulite Cure?

Kourtney Kardashian Barker’s supplement brand, Lemme, has faced significant scrutiny following the launch of its new “Ozempic-style” weight-loss supplement, GLP-1 Daily. This comes amidst years of claims that the Kar-Jenner sisters, including Kim Kardashian, Khloe, and Kylie, have used Ozempic—a drug originally for diabetes that gained popularity as a weight-loss aid in 2022. Lemme’s new product is accused of capitalizing on this trend, despite not containing the same key ingredients as the prescription drug.
Ozempic is a weekly injectable medication that utilizes a synthetic version of the GLP-1 hormone, naturally released by the body after eating. When injected, this man-made hormone slows digestion, reduces hunger, and promotes weight loss. Its use by celebrities, such as Lottie Moss who suffered a seizure from an overdose, has further amplified its presence in pop culture.
Lemme’s GLP-1 Daily supplement is directly named after the Ozempic hormone and is marketed to “reduce body weight, visceral fat, and hip and waist circumference.” While Lemme emphasizes its product uses natural ingredients like lemon and saffron extracts to purportedly increase GLP-1 levels over time, it explicitly avoids the synthetic GLP-1 found in Ozempic. Despite this, Kourtney promoted an article that discussed her desire to be “in on the Ozempic boom,” and brand emails described the supplement as “a GLP-1 solution without the side effects” of Ozempic.
The product has drawn immediate criticism from fans and medical experts alike. Many fans, who remember Kourtney’s past outspokenness on body positivity, accused her of creating a “facade” and engaging in “false marketing” to exploit insecurities. The pills are also expensive, costing £69 for a one-time purchase of 30 servings, or £55.23 with a monthly subscription.
Doctors and plastic surgeons have also expressed strong skepticism about the supplement’s effectiveness. Naveen Cavale, a plastic surgeon at Real Plastic Surgery, criticized Kourtney for “cashing in” on young women struggling with body image, calling the product “incredibly misleading.” He warned that such products offer “false hope while offering little in terms of real results” and could exacerbate mental health issues like anxiety, stress, and depression by leading to frustration and feelings of failure due to ineffective outcomes.
Cavale further explained that Ozempic contains semaglutide, a rigorously tested GLP-1 receptor proven to promote significant weight loss by regulating blood sugar, reducing appetite, and slowing digestion. Lemme’s supplement lacks this key ingredient. He clarified that if it did contain GLP-1, it would be classified as a drug, not a supplement. Despite claims of boosting GLP-1 levels with plant-based extracts, Cavale asserted there is “little to no clinical evidence to support significant weight loss from these ingredients.”
A critical detail is Lemme’s small print disclaimer, which states its claims have not been evaluated by the Food and Drug Administration (FDA) and that the product is “not intended to diagnose, treat, cure or prevent any disease.” This is significant because FDA approval ensures products have been thoroughly tested for efficiency and safety, a standard not met by Lemme’s supplements.
Kourtney Kardashian launched Lemme in September 2022, following her long-standing reputation as the most health-conscious Kardashian sister, known for strict diets and a wellness focus sparked by the birth of her eldest son, Mason. However, Lemme has faced multiple controversies prior to the GLP-1 Daily release.
In February of the previous year, Lemme launched “Lemme Purr,” vagina gummies marketed to boost vaginal health and alter taste. This product drew sharp condemnation from gynecologist Dr. Jen Gunter, author of ‘The Vagina Bible’, who called it a “misogynist and awful” “grift,” particularly challenging the notion that a vagina needs an improved taste or freshness.
Similarly, in June, Lemme released “Smooth” capsules, claiming to reduce cellulite in just 28 days using ingredients like French Cantaloupe Melon (SOD B Dimpless). Again, medical experts, including Naveen Cavale, dismissed these as a “fad” and an “ineffective solution to a perfectly normal condition,” emphasizing that cellulite is natural and common, and such pills lack scientific backing. The same FDA disclaimer applies to these products as well, reinforcing concerns about their efficacy and safety claims.
You may also like...
When Sacred Calendars Align: What a Rare Religious Overlap Can Teach Us
As Lent, Ramadan, and the Lunar calendar converge in February 2026, this short piece explores religious tolerance, commu...
Arsenal Under Fire: Arteta Defiantly Rejects 'Bottlers' Label Amid Title Race Nerves!

Mikel Arteta vehemently denies accusations of Arsenal being "bottlers" following a stumble against Wolves, which handed ...
Sensational Transfer Buzz: Casemiro Linked with Messi or Ronaldo Reunion Post-Man Utd Exit!

The latest transfer window sees major shifts as Manchester United's Casemiro draws interest from Inter Miami and Al Nass...
WBD Deal Heats Up: Netflix Co-CEO Fights for Takeover Amid DOJ Approval Claims!

Netflix co-CEO Ted Sarandos is vigorously advocating for the company's $83 billion acquisition of Warner Bros. Discovery...
KPop Demon Hunters' Stars and Songwriters Celebrate Lunar New Year Success!

Brooks Brothers and Gold House celebrated Lunar New Year with a celebrity-filled dinner in Beverly Hills, featuring rema...
Life-Saving Breakthrough: New US-Backed HIV Injection to Reach Thousands in Zimbabwe

The United States is backing a new twice-yearly HIV prevention injection, lenacapavir (LEN), for 271,000 people in Zimba...
OpenAI's Moral Crossroads: Nearly Tipped Off Police About School Shooter Threat Months Ago
ChatGPT-maker OpenAI disclosed it had identified Jesse Van Rootselaar's account for violent activities last year, prior ...
MTN Nigeria's Market Soars: Stock Hits Record High Post $6.2B Deal
MTN Nigeria's shares surged to a record high following MTN Group's $6.2 billion acquisition of IHS Towers. This strategi...

:max_bytes(150000):strip_icc()/Health-canned-tuna-recall-0c680cece98e4994b64a8d6a0d06247d.png)
:max_bytes(150000):strip_icc()/Health-super-greens-recall-57be62c936b14cbfb489ca7653de995c.png)
:max_bytes(150000):strip_icc()/HDC-Hummus-Recall2-2ae77744c31d4bb390228493d63e8186.png)
:max_bytes(150000):strip_icc()/Health-GettyImages-2227107996-ea68ba3036d747d79ad338826a497f9b.jpg)